ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹4,783 Cr | ₹3,961 Cr | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr |
What is the latest Total Current Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹4,783 Cr |
| Mar2025 | ₹3,961 Cr |
| Mar2024 | ₹3,995 Cr |
| Mar2023 | ₹3,707 Cr |
| Mar2022 | ₹4,805 Cr |
How is Total Current Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,783 Cr | 20.75 | |
| Mar2025 | ₹3,961 Cr | -0.85 | |
| Mar2024 | ₹3,995 Cr | 7.75 | |
| Mar2023 | ₹3,707 Cr | -22.85 | |
| Mar2022 | ₹4,805 Cr | - | |
Compare Total Current Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹63,411.9 Cr | 2% | 1.2% | -6.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 2% |
1.2% |
-6.4% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses